Rare diseases
Investigational molecules
Locations
53 Frontage Road Suite 220, 08827-4034, United States
Celldex Therapeutics Inc. focuses on chronic spontaneous urticaria and chronic inducible urticaria, including cold-induced urticaria and symptomatic dermographism. Its clinical work in this area centers on persistent wheal-and-itch disease burden and provocation-test outcomes.
The sponsor’s studies in urticaria span multiple active sites across several countries, reflecting a broad interest in mast cell–driven skin disease and symptom control.
Celldex Therapeutics Inc. runs clinical trials in conditions such as Chronic spontaneous urticaria, Cold urticaria, Neurodermatitis, Eosinophilic oesophagitis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
Belgium
CroatiaBelgium
BulgariaGermanyBulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
